PAPER Mahmoudi E, Lin P, Peterson MD, Meade M, Tate DG, Kamdar N
SEARCH RESULTS
276091 RESULTS
PAPER Dodich A, Crespi C, Santi GC, Marcone A, Iannaccone S, Perani D, Cappa SF, Cerami C
Emotion Recognition Deficits in the Differential Diagnosis of Amnestic Mild Cognitive Impairment: A Cognitive Marker for the Limbic-Predominant Phenotype.
J Int Neuropsychol Soc. 2021 Mar 22;:1-7. PubMed: 33745493PAPER Chauhan PS, Mishra M, Koul B, Sharma M, Yadav D
Modifiable Risk Factors Associated with Alzheimer's Disease with Special Reference to Sleep Disturbance.
CNS Neurol Disord Drug Targets. 2021 Mar 19; PubMed: 33745437PAPER Michiels L, Van Weehaeghe D, Vandenberghe R, Demeestere J, Van Laere K, Lemmens R
The Role of Amyloid PET in Diagnosing Possible Transmissible Cerebral Amyloid Angiopathy in Young Adults with a History of Neurosurgery: A Case Series.
Cerebrovasc Dis. 2021 Mar 19;:1-5. PubMed: 33744891PAPER Gustafson DR
Epidemiology Informs Randomized Clinical Trials of Cognitive Impairments and Late-Onset, Sporadic Dementias.
J Neurol Neuromedicine. 2018;3(5):13-18. PubMed: 33748680PAPER Aum S, Choe S, Cai M, Jerng UM, Lee JH
Moxibustion for cognitive impairment: a systematic review and meta-analysis of animal studies.
Integr Med Res. 2021 Jun;10(2):100680. Epub 2020 Oct 14 PubMed: 33747784PAPER Ohno M
Accelerated long-term forgetting is a BACE1 inhibitor-reversible incipient cognitive phenotype in Alzheimer's disease model mice.
Neuropsychopharmacol Rep. 2021 Mar 22; PubMed: 33749160PAPER Granatiero V, Sayles NM, Savino AM, Konrad C, Kharas MG, Kawamata H, Manfredi G
Modulation of the IGF1R-MTOR pathway attenuates motor neuron toxicity of human ALS SOD1G93A astrocytes.
Autophagy. 2021 Mar 22;:1-14. PubMed: 33749521PAPER Russo K, Wharton KA
BMP/TGF-β signaling as a modulator of neurodegeneration in ALS.
Dev Dyn. 2021 Mar 21; PubMed: 33745185PAPER Beales A, Whitworth A, Cartwright J, Panegyres PK, Kane RT
Making the Right Connections: Maximizing Lexical Generalization in Lexical Impairments in Primary Progressive Aphasia and Alzheimer's Disease.
Am J Speech Lang Pathol. 2021 Mar 26;30(2):697-712. Epub 2021 Mar 22 PubMed: 33751904PAPER
Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions.
J Alzheimers Dis. 2021;80(2):905. PubMed: 33749659PAPER Malik R, Georgakis MK, Neitzel J, Rannikmäe K, Ewers M, Seshadri S, Sudlow CL, Dichgans M
Midlife vascular risk factors and risk of incident dementia: Longitudinal cohort and Mendelian randomization analyses in the UK Biobank.
Alzheimers Dement. 2021 Mar 22; PubMed: 33749976PAPER Grober E, Wang C, Kitner-Triolo M, Lipton RB, Kawas C, Resnick SM
Prognostic Value of Learning and Retention Measures from the Free and Cued Selective Reminding Test to Identify Incident Mild Cognitive Impairment.
J Int Neuropsychol Soc. 2021 Mar 22;:1-8. PubMed: 33745492PAPER Harb AA, Chen R, Chase HS, Natarajan K, Noble JM
Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave.
J Alzheimers Dis. 2021 Mar 13; PubMed: 33749656PAPER Lemprière S
Distinct microglial profiles associated with amyloid and tau pathology in Alzheimer disease.
Nat Rev Neurol. 2021 Apr;17(4):194. PubMed: 33750932Current Filters
- Date Range : All x